Brief considerations on the dispensation profile of the botulinum toxin type A by the Brazilian Unified Health System for treatment of dystonias: Datasus data

Botulinum toxin injections are the most effective approach for the treatment of focal dystonia. Despite growing demand and clinical indications over the years, there are few reports or publications of its use and benefit to patients seen at the Sistema Único de Saúde - SUS (Unified Health System). A...

Descripción completa

Detalles Bibliográficos
Autores principales: Chien, Hsin Fen, Rosso, Ana Lucia Zuma de, Santos, André Sobierajski dos, Rieder, Carlos Roberto de Mello, Maia, Debora Palma, Silva, Delson José da, Andrade, Marcio da Cunha, Coletta, Marcus Vinicius Della, Costa, Maria do Desterro Leiros da, Allam, Nasser, Prado, Roberto César Pereira do, Borges, Vanderci, Tumas, Vitor, Horta, Wagner de Goes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5803103/
https://www.ncbi.nlm.nih.gov/pubmed/29430552
http://dx.doi.org/10.1016/j.ensci.2016.07.001
Descripción
Sumario:Botulinum toxin injections are the most effective approach for the treatment of focal dystonia. Despite growing demand and clinical indications over the years, there are few reports or publications of its use and benefit to patients seen at the Sistema Único de Saúde - SUS (Unified Health System). Analyzing the Datasus data (Unified Health System Information Department of Brazilian Ministry of Health), it was noticed that in Brazil the percentage of dystonic patient benefited from this procedure is still low. We therefore suggest some strategies to increase the dispensation of the toxin by the Brazilian Unified Health system for the dystonic patients.

Ejemplares similares